Opportunity Information: Apply for RFA DC 12 001
Apply for RFA DC 12 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Improving Access to Hearing Health Care (SBIR) R43/R44" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173 Research Related to Deafness and Communication Disorders.
- This funding opportunity was created on Oct 26, 2011 and posted on Dec 20, 2010.
- Applicants must submit their applications by Oct 26, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Improving Access to Hearing Health Care (SBIR) R43/R44 (Funding Opportunity Number RFA-DC-12-001) is a discretionary NIH grant opportunity under CFDA 93.173, Research Related to Deafness and Communication Disorders. The purpose of this announcement is to fund Small Business Innovation Research (SBIR) projects that develop and translate practical technologies aimed at improving hearing health care outcomes. A central requirement of the program is that proposed innovations must be designed to increase the utilization of hearing health care technology among underserved patients, with the explicit goal of reducing health disparities in access, uptake, and outcomes related to hearing care.
The eligible applicants are small business concerns, meaning the program is specifically structured to move new products and services from early-stage research into development pathways that can realistically reach patients and clinicians. The funding mechanism is the SBIR phased approach using the NIH R43/R44 framework. In general terms, this structure supports early feasibility and proof-of-concept work (Phase I, typically associated with R43) and then supports more advanced research and development steps toward commercialization (Phase II, typically associated with R44), helping small companies bridge the gap between invention and real-world implementation. While the listing does not spell out the scientific topics in detail, the focus is clearly on technology development and translation that measurably improves access and use, not simply basic research about hearing.
Financially, the opportunity listed an estimated total funding level of $4,000,000, with an award ceiling shown as $150,000. The announcement states that there is no cost sharing or matching requirement, which means applicants are not required to contribute non-federal funds as a condition of receiving an award. The funding instrument type is a grant, and the activity category is health, reflecting NIH's mission-oriented support for innovations that can be adopted in real care settings.
In terms of timing and status, the FOA was posted on December 20, 2010, with an original closing date of July 18, 2012; however, the record also shows a current closing date of October 26, 2011 and an archive date of November 26, 2011, indicating that the opportunity is archived and no longer open for new submissions under that specific announcement. The agency is the National Institutes of Health, and the provided additional information link points to the official NIH Grants Guide page for the FOA. For technical issues accessing the announcement or troubleshooting links, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Overall, this grant opportunity was designed to push small business-led innovation toward real improvements in hearing health care delivery, with an emphasis on technologies that underserved populations will actually be able to obtain, use, and benefit from, thereby narrowing persistent gaps in hearing care access and outcomes.
Frequently Asked Questions (FAQs)
What is the official title of this funding opportunity?
The opportunity is titled Improving Access to Hearing Health Care (SBIR) R43/R44.
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is RFA-DC-12-001.
Which agency is offering this grant opportunity?
The offering agency is the National Institutes of Health (NIH).
Is this a discretionary grant program?
Yes. This is described as a discretionary NIH grant opportunity.
What CFDA program does this opportunity fall under?
This opportunity is under CFDA 93.173, Research Related to Deafness and Communication Disorders.
What is the main purpose of this FOA?
The purpose is to fund Small Business Innovation Research (SBIR) projects that develop and translate practical technologies aimed at improving hearing health care outcomes.
What is the central requirement for proposed innovations?
A central requirement is that innovations must be designed to increase the utilization of hearing health care technology among underserved patients, with the explicit goal of reducing health disparities in access, uptake, and outcomes related to hearing care.
Who is eligible to apply?
Eligible applicants are small business concerns. The program is structured specifically for small businesses to move new products and services from early-stage research into development pathways that can realistically reach patients and clinicians.
What funding mechanism does this opportunity use?
The funding mechanism is the NIH SBIR phased approach using the R43/R44 framework.
What do Phase I and Phase II generally support under R43/R44?
In general terms, Phase I (typically associated with R43) supports early feasibility and proof-of-concept work, while Phase II (typically associated with R44) supports more advanced research and development steps toward commercialization.
Is the focus basic research or technology development?
The focus is on technology development and translation that measurably improves access and use, not simply basic research about hearing.
What is the estimated total funding level for this opportunity?
The listing provides an estimated total funding level of $4,000,000.
What is the award ceiling listed for this opportunity?
The award ceiling is shown as $150,000.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
What type of funding instrument is used?
The funding instrument type is a grant.
What is the activity category for this FOA?
The activity category is health.
When was the FOA posted?
The FOA was posted on December 20, 2010.
What dates are listed for closing and archiving?
The record lists an original closing date of July 18, 2012, and it also shows a current closing date of October 26, 2011 with an archive date of November 26, 2011.
Is this funding opportunity still open?
No. The information indicates the opportunity is archived and no longer open for new submissions under that specific announcement.
Where can applicants find the official NIH posting for this FOA?
The additional information link points to the official NIH Grants Guide page for the FOA.
Who should be contacted for technical issues accessing the announcement or links?
For technical issues, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
What overall impact was this program designed to achieve?
It was designed to push small business-led innovation toward real improvements in hearing health care delivery, emphasizing technologies that underserved populations can obtain, use, and benefit from, thereby narrowing persistent gaps in hearing care access and outcomes.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Assessment of the Criminal Justice Sector in Iraq
Previous opportunity: Improving Access to Hearing Health Care (STTR) R41/R42
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DC 12 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DC 12 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Ability of Individual and Integrated Tick Management (ITM) Technologies to Reduce the Entomological Risk of Lyme Disease Apply for RFA CK 11 005 Funding Number: RFA CK 11 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Combining Subjective and Objective Methods for Quantifying Contact Rates and Mixing Pattern in School Aged Children Apply for RFA CK 11 006 Funding Number: RFA CK 11 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R21) Apply for PAR 11 083 Funding Number: PAR 11 083 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R01) Apply for PAR 11 082 Funding Number: PAR 11 082 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Spina Bifida Registry Longitudinal Data Collection and Evaluation (U01) Apply for RFA DD 11 005 Funding Number: RFA DD 11 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| NIAID Science Education Awards (R25) Apply for PAR 11 086 Funding Number: PAR 11 086 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Georgia Tuberculosis Prevention Project Apply for RFA 114 11 000001 Funding Number: RFA 114 11 000001 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $4,450,000 |
| Studies at the Animal Human Interface of Influenza and Other Zoonotic Diseases in Vietnam Apply for RFA IP 11 005 Funding Number: RFA IP 11 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Influenza and Other Respiratory Diseases in Southern Hemisphere Apply for RFA IP 11 014 Funding Number: RFA IP 11 014 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Campus Suicide Prevention Grants Apply for SM 11 002 Funding Number: SM 11 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $102,000 |
| Cooperative Agreements for State Sponsored Youth Suicide Prevention and Early Intervention Apply for SM 11 001 Funding Number: SM 11 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $480,000 |
| Cooperative Agreement with the Catholic Relief Services (CRS) Apply for CDC RFA GH11 11104 Funding Number: CDC RFA GH11 11104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection Among Children and Adults in India Apply for RFA IP 11 012 Funding Number: RFA IP 11 012 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Influenza Vaccine Efficacy in Tropical and Developing Countries Apply for RFA IP 11 013 Funding Number: RFA IP 11 013 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,250,000 |
| HIT Capacity Building Initiative for Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Grantee Sites Apply for HRSA 11 101 Funding Number: HRSA 11 101 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Sustainable Responses for Improving the Lives of Vulnerable Children and their Households Apply for RFA 617 11 000001 Funding Number: RFA 617 11 000001 Agency: Uganda USAID Kampala Category: Health Funding Amount: $29,500,000 |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R01) Apply for PA 11 087 Funding Number: PA 11 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R03) Apply for PA 11 088 Funding Number: PA 11 088 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol Related Public Policies such as Those Detailed in the Alcohol Policy Information System (R21) Apply for PA 11 089 Funding Number: PA 11 089 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NHLBI Investigator Initiated Resource Related Research Projects (R24) Apply for PAR 11 090 Funding Number: PAR 11 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DC 12 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.